| |
| |
|
| Insider
Information: |
Bjerkholt Eric |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
574,968 |
|
|
Indirect Shares
|
83,827 |
|
|
| Direct
Value |
$682,195 |
|
|
|
Indirect Value
|
$56,483 |
|
|
| Total
Shares |
658,795 |
|
|
| Total
Value |
$738,677 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
4
|
|
Stock
price went up :
|
5
|
4
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
5.0
|
4.0
|
| Percentage
Gain/Loss : |
 46.5%
|
276.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Viracta Therapeutics Ord Shs |
VIRX |
EVP, CFO & Corp. Secre... |
2016-02-29 |
100,922 |
2016-02-29 |
83,827 |
Premium* |
|
|
Microbot Medical Inc |
MBOT |
Director |
2016-01-01 |
273,759 |
2010-03-01 |
0 |
Premium* |
|
|
Corium International, Inc. |
CORI |
Director |
2016-05-18 |
0 |
2018-11-27 |
0 |
Premium* |
|
|
Aimmune Therapeutics, Inc. |
AIMT |
Chief Financial Officer |
2020-10-13 |
0 |
2017-05-12 |
0 |
Premium* |
|
|
Cerus Corp |
CERS |
Director |
2024-06-05 |
182,133 |
2019-10-04 |
0 |
Premium* |
|
|
Chinook Therapeutics Inc |
KDNY |
Chief Financial Officer |
2023-08-11 |
0 |
|
0 |
Premium* |
|
|
Calcimedica Ord Shs |
CALC |
Director |
2023-05-31 |
3,684 |
2023-03-23 |
0 |
Premium* |
|
|
Mirum Pharmaceuticals, Inc. |
MIRM |
|
2024-05-10 |
14,470 |
2023-09-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
83 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CERS |
Cerus Corp |
Director |
– • – |
2020-01-29 |
4 |
B |
$4.15 |
$83,000 |
D/D |
20,000 |
24,282 |
2.39 |
% |
|
| CERS |
Cerus Corp |
Director |
– • – |
2020-10-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,281 |
28,563 |
0 |
- |
|
| CERS |
Cerus Corp |
Director |
– • – |
2021-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,228 |
41,791 |
0 |
- |
|
| CERS |
Cerus Corp |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
14,888 |
56,679 |
0 |
- |
|
| CERS |
Cerus Corp |
Director |
– • – |
2022-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,454 |
77,133 |
0 |
- |
|
| CERS |
Cerus Corp |
Director |
– • – |
2023-05-23 |
4 |
B |
$2.00 |
$10,000 |
D/D |
5,000 |
82,133 |
2.39 |
% |
|
| CERS |
Cerus Corp |
Director |
– • – |
2023-06-07 |
4 |
A |
$5.00 |
$200,000 |
D/D |
40,000 |
122,133 |
0 |
- |
|
| CERS |
Cerus Corp |
Director |
– • – |
2023-08-21 |
4 |
B |
$1.72 |
$17,151 |
D/D |
10,000 |
132,133 |
2.39 |
% |
|
| CERS |
Cerus Corp |
Director |
– • – |
2023-12-13 |
4 |
B |
$1.62 |
$16,200 |
D/D |
10,000 |
142,133 |
2.39 |
% |
|
| CERS |
Cerus Corp |
Director |
– • – |
2024-06-05 |
4 |
A |
$5.00 |
$200,000 |
D/D |
40,000 |
182,133 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial OfficerOfficer |
• – – |
2020-11-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-12-01 |
4 |
D |
$16.02 |
$92,097 |
D/D |
(5,750) |
20,664 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,414 |
26,414 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,434 |
23,098 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-02-11 |
4 |
S |
$12.74 |
$11,403 |
D/D |
(895) |
22,203 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-11-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,414 |
38,617 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-12-01 |
4 |
S |
$22.29 |
$128,602 |
D/D |
(5,770) |
32,847 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-01-31 |
4 |
S |
$24.68 |
$71,357 |
D/D |
(2,891) |
37,289 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,333 |
40,180 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,435 |
39,724 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-02-10 |
4 |
S |
$23.75 |
$20,352 |
D/D |
(857) |
38,867 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-08-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(39,371) |
0 |
0 |
- |
|
| CORI |
Corium International, Inc... |
Director |
– • – |
2016-05-18 |
4 |
B |
$3.54 |
$36,867 |
I/I |
10,369 |
5,659 |
2.1 |
- |
|
| CORI |
Corium International, Inc... |
Director |
– • – |
2016-05-19 |
4 |
B |
$3.70 |
$52,333 |
I/I |
14,131 |
12,000 |
2.1 |
- |
|
| CORI |
Corium International, Inc... |
Director |
– • – |
2018-11-27 |
4 |
D |
$12.50 |
$306,250 |
I/I |
(24,500) |
0 |
0 |
- |
|
83 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
